Complete Genomics Adds $69M
Complete Genomics (NASDAQ: GNOM), the Mountain View, CA-based company that sequences entire human genomes for researchers, has raised about $69 million in a new stock offering. The company sold 5.5 million shares at $12.50 apiece, a 6 percent discount to the closing market price the day before the deal was announced. The offering got a better reception than the company’s IPO from November—in which shares were sold for $9, and tumbled to $8.03 in the first day of trading. Complete Genomics ended the week at $14.33, with a market valuation of $372 million.